DS
CRMD icon

DRW Securities’s CorMedix CRMD Stock Holding History

DRW Securities’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.7K Buy
+11,172
New +$88.3K ﹤0.01% 880
2025
Q4 		– Sell
-14,618
Closed -$167K – 1311
2025
Q3 		$167K Buy
+14,618
New +$177K ﹤0.01% 1118

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DRW Securities's CRMD Position: Q2 2026 in Review

DRW Securities opened a new position in CorMedix (CRMD) in Q2 2026: 11,172 shares worth $87.7K. The stake represents ﹤0.01% of the portfolio and ranks #880 among its holdings. This is a return to the name: DRW Securities previously reported a position in CRMD as recently as Q3 2025.

DRW Securities first reported a position in CRMD in Q3 2025 and has held it in 2 quarters since. The position peaked at $167K in Q3 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • DRW Securities held 11,172 shares of CorMedix worth $87.7K as of Q2 2026.
  • CorMedix was a new DRW Securities position in Q2 2026.
  • CorMedix made up ﹤0.01% of DRW Securities's portfolio in Q2 2026, its #880 holding.
  • DRW Securities first reported a position in CorMedix in Q3 2025 and has held it in 2 quarters since.
  • DRW Securities's CorMedix position peaked at $167K in Q3 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.